Vaccine Safety Conference Session 17 - Christopher A. Shaw, Ph.D, Professor

Aluminum as a Neurotoxin: the Evidence from Cell Culture, in Vivo


Dr. Christopher Shaw is a Professor in the Department of Ophthalmology and Visual Sciences at the University of British Columbia and holds cross appointments with the Department of Experimental Medicine and the Graduate Program in Neuroscience. He is the author of more than 100 peer-reviewed articles as well as numerous book chapters and special reviews. Shaw has edited four books on neuroscience themes. The main focus of his research has been on the Guamanian neurological disease spectrum, ALS-parkinsonism dementia complex (ALS-PDC). Recent work in the laboratory has developed animal models of the disease that are able to recapitulate all the essential behavioural and pathological features. The model is also being used to understand gene-toxin interactions, define neurodegeneration pathways involved, and to attempt therapeutic interventions at early, mid and late time points. Work in the laboratory also provided one of the first models of aluminum adjuvant-induced neuropathology and these studies have become a new research direction. He is the founder and a former director of Neurodyn, a biotechnology company based out of Prince Edward Island. Neurodyn's efforts are directed at early phase detection and treatment for age-related neurological disorders. He has two children. The youngest has not been vaccinated. Produced by Northica.media for NVIC.

Category:

Science & Technology

Tags:

• Vaccines
• Vaccine Safety
• Science
• NVIC
• aluminum
• adjuvants
• autoimmunity
• Autoimmune
• autism
• vaccine research